Should Angiotensin Receptor Neprilysin Inhibitors Replace Angiotensin-converting Enzyme Inhibitors in Heart Failure With a Reduced Ejection Fraction?

Angiotensin-converting enzyme inhibitors (ACEIs) have been the cornerstone of treatment of heart failure with reduced ejection fraction (HFrEF) for over two decades. Inhibition of neprilyisin augments vasoactive substances including natriuretic peptides, which may have multiple advantageous effects...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Card Fail Rev
Hauptverfasser: Hayman, Sam, Atherton, John J
Format: Artigo
Sprache:Inglês
Veröffentlicht: Radcliffe Cardiology 2016
Schlagworte:
Pharmacological Therapy
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5490929/
https://ncbi.nlm.nih.gov/pubmed/28785452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/cfr.2016:2:2
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge